SNHG7 and thyroid gland carcinoma: Multiple studies have confirmed that SNHG7 is significantly overexpressed in thyroid cancer tissues and cell lines (13–17), with its upregulation closely associated with increased tumor diameter, TNM staging, and poor patient prognosis (14, 15).